We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Annual Reprint of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1933 with the Comments That Have Appeared in The Journal

JAMA. 1934;102(22):1875. doi:10.1001/jama.1934.02750220053028.
Text Size: A A A
Published online


A feature of marked current interest in this volume is the preliminary report on alpha-dinitrophenol, the new drug for acceleration of cellular metabolism. The Council voices a warning on the dangers attending the use of this drug; this warning has been increasingly justified in reports of fatalities since the appearance of the Council's report in July of last year. Other preliminary reports which make this volume one of the most interesting issued by the Council in recent years are those on Dilaudid, a new narcotic drug related to morphine; Fuadin, a new antimony compound for use in the treatment of bilharziasis and granuloma inguinale, and Hippuran, a new product for intravenous and oral urography.

The comprehensive and definitive special report on estrogenic substances furnishes a much needed review of the present status of such products in gynecologic therapy. The Council insists on the doctrine that basic laboratory investigation of these


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.